Piramal Pharma Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '25 Apr 24, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Market Capitalization	296,464	170,528	81,683	-	-
Market Cap Growth	92.16%	108.77%	-	-	-
Enterprise Value	340,244	209,922	130,128	-	-
Last Close Price	223.62	128.81	66.80	-	-
PE Ratio	762.12	956.95	-	-	-
Forward PE	127.78	42.33	40.39	-	-
PS Ratio	3.31	2.09	1.15	-	-
PB Ratio	3.75	2.15	1.21	-	-
P/TBV Ratio	7.95	4.71	3.51	-	-
P/FCF Ratio	-	58.30	-	-	-
P/OCF Ratio	-	16.98	16.88	-	-
PEG Ratio	1.70	1.58	1.35	-	-
EV/Sales Ratio	3.80	2.57	1.84	-	-
EV/EBITDA Ratio	23.03	18.43	22.58	-	-
EV/EBIT Ratio	47.44	45.62	-	-	-
EV/FCF Ratio	-	71.77	-	-	-
Debt / Equity Ratio	0.61	0.60	0.83	0.62	0.54
Debt / EBITDA Ratio	3.40	4.00	9.21	3.63	2.30
Debt / FCF Ratio	-	16.10	-	-	-
Asset Turnover	-	0.55	0.52	0.57	-
Inventory Turnover	-	1.69	1.94	1.87	-
Quick Ratio	-	0.61	0.64	0.69	0.82
Current Ratio	-	1.25	1.26	1.34	1.47
Return on Equity (ROE)	-	0.24%	-2.77%	6.11%	-
Return on Assets (ROA)	-	1.93%	-0.20%	2.96%	-
Return on Capital (ROIC)	3.24%	2.30%	-0.24%	3.60%	-
Return on Capital Employed (ROCE)	-	4.20%	-	5.70%	10.50%
Earnings Yield	0.13%	0.10%	-2.28%	-	-
FCF Yield	-	1.71%	-5.89%	-	-
Dividend Yield	0.05%	0.08%	-	-	-
Payout Ratio	-	-	-	13.30%	-
Buyback Yield / Dilution	-8.30%	-7.85%	-0.95%	-87.83%	-
Total Shareholder Return	-8.25%	-7.76%	-0.95%	-87.83%	-

Updated Jan 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.